Clinical Trials, Phase IV as Topic

Works about planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.

Year introduced: 2008(1993)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): E05.318.372.250.250.230, E05.337.800.200, N05.715.360.330.250.250.230, N06.850.520.450.250.250.230

MeSH Unique ID: D017327

Entry Terms:

• Clinical Trials, Phase 4 as Topic
• Drug Evaluation, FDA Phase IV as Topic
• Evaluation Studies, FDA Phase IV as Topic
• Evaluation Studies, FDA Phase 4 as Topic
• Drug Evaluation, FDA Phase 4 as Topic

Previous Indexing:

• Clinical Trials (1980-1992)

See Also:

• Drug-Related Side Effects and Adverse Reactions

All MeSH Categories
Analytical, Diagnostic and Therapeutic Techniques and Equipment Category
Investigative Techniques
Epidemiologic Methods
Epidemiologic Study Characteristics
Clinical Studies as Topic
Clinical Trials as Topic
Clinical Trials, Phase IV as Topic

All MeSH Categories
Analytical, Diagnostic and Therapeutic Techniques and Equipment Category
Investigative Techniques
Evaluation Studies as Topic
Product Surveillance, Postmarketing
Clinical Trials, Phase IV as Topic

All MeSH Categories
Health Care Category
Health Care Quality, Access, and Evaluation
Quality of Health Care
Health Care Evaluation Mechanisms
Epidemiologic Study Characteristics
Clinical Studies as Topic
Clinical Trials as Topic
Clinical Trials, Phase IV as Topic

All MeSH Categories
Health Care Category
Environment and Public Health
Public Health
Epidemiologic Methods
Epidemiologic Study Characteristics
Clinical Studies as Topic
Clinical Trials as Topic
Clinical Trials, Phase IV as Topic